Top Markets
Coin of the day
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc.

AURX
Rank in Stocks #25551
Nuo Therapeutics, Inc. operates as a regenerative medicine company,... Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inherent capacity for natural healing, with a primary focus on the United States market. Central to their offerings is a technology that isolates components from a patient's own blood (autologous) to generate a platelet-based therapy, specifically tailored for the treatment of chronic wounds. Established in Houston, Texas, in 1998, the company underwent a name change from Cytomedix, Inc. to Nuo Therapeutics, Inc. in November 2014.
Share Price
$1.00
Last synced: 2026-08-19
Market Cap
$48.41M
Change (1 day)
0.00%
Change (1 year)
-41.86%
Country
US
Trade Nuo Therapeutics, Inc. (AURX)

Category

Price of AURX with the market cap of B
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
AURX
$1.00
Market Capitalization of Nuo Therapeutics, Inc.(AURX)
Market Cap: $48.41M
As of August 2026 Nuo Therapeutics, Inc. has a market cap of $48.41M. This makes Nuo Therapeutics, Inc. the world's 25551st most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Nuo Therapeutics, Inc. from 2017 to 2026
AURX compared with Top 5 Most Popular stocks
Price of AURX Asset B Mkt. of B Results
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$108,592 $48.41M
$5.257T +10,859,108.56%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$94,995.50 $48.41M
$4.599T +9,499,449.68%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$84,830.71 $48.41M
$4.107T +8,482,970.80%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$73,896.21 $48.41M
$3.577T +7,389,521.11%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$57,991.20 $48.41M
$2.807T +5,799,020.33%